Bryan D. Olin

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX.

ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL.

Lifescan, Inc. engages in the development, manufacture, and market of blood glucose monitoring products. Its portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The company was founded by Gary H. Stroy in 1981 and is headquartered in Wayne, PA.

cerbomed GmbH manufactures and supplies medical devices for treating epilepsy. It offers NEMOS, a transcutaneous vagus nerve stimulation unit that treats epilepsy patients. The company was founded by Stefan Dietrich and Timo Freitag in 2005 and is headquartered in Erlangen, Germany.

Medical Device Innovation Consortium (MDIC) is a collective endeavor focused on realizing the potential of transformative innovation in the medical device industry. The private company is based in St. Louis Park, MN. The company encourages med device companies to adopt advanced technologies such as AI, ML, and IoT to develop supply resiliency, production agility, innovation rigor, and secure medical product supply. MDIC's CFQ program is a dynamic collaborative exchange and engagement of diverse experiences and professional insights in advancing innovation to the forefront of patient safety and accessibility. The company was founded by William A. Hawkins. Andrew Fish has been the CEO of the company since 2022.